Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip J Tofilon

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Oncology (Williston Park, N.Y.)|April 6, 2010
HDAC inhibitors in cancer carePhilip J Tofilon, Kevin Camphausen
Cancer Biology & Therapy|April 27, 2004
Combining radiation and molecular targeting in cancer therapyKevin Camphausen, Philip J Tofilon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Inhibition of histone deacetylation: a strategy for tumor radiosensitizationKevin Camphausen, Philip J Tofilon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Inhibition of Hsp90: a multitarget approach to radiosensitizationKevin Camphausen, Philip J Tofilon
Molecular Cancer Therapeutics|December 23, 2025
The proteasome is revealed as a therapeutic target in recurrent glioblastoma xenograftsCharlotte Degorre, Philip J Tofilon
Molecular Cancer Therapeutics|January 7, 2026
The Proteasome Is Revealed as a Therapeutic Target in Recurrent Glioblastoma XenograftsCharlotte Degorre, Philip J Tofilon
Molecular Biology of the Cell|October 22, 2002
Radiation-induced activation of nuclear factor-kappaB involves selective degradation of plasma membrane-associated I(kappa)B(alpha)Jeffery S Russell, Philip J Tofilon
Radiation Oncology (London, England)|December 29, 2012
Preclinical models in radiation oncologyJenna Kahn, Philip J Tofilon, Kevin Camphausen
Current Topics in Developmental Biology|June 20, 2006
Histone deacetylation as a target for radiosensitizationDavid Cerna, Kevin Camphausen, Philip J Tofilon
International Journal of Molecular Sciences|September 13, 2025
Radiation Modifies Let-7 miRNA Binding to AGO2 Independent of Changes in Transcription to Influence Tumor Cell RadiosensitivityTaqveema Ali, Charlotte Degorre, Philip J Tofilon
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Oncology (Williston Park, N.Y.)|April 6, 2010
HDAC inhibitors in cancer carePhilip J Tofilon, Kevin Camphausen
Cancer Biology & Therapy|April 27, 2004
Combining radiation and molecular targeting in cancer therapyKevin Camphausen, Philip J Tofilon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Inhibition of histone deacetylation: a strategy for tumor radiosensitizationKevin Camphausen, Philip J Tofilon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Inhibition of Hsp90: a multitarget approach to radiosensitizationKevin Camphausen, Philip J Tofilon
Molecular Cancer Therapeutics|December 23, 2025
The proteasome is revealed as a therapeutic target in recurrent glioblastoma xenograftsCharlotte Degorre, Philip J Tofilon
Molecular Cancer Therapeutics|January 7, 2026
The Proteasome Is Revealed as a Therapeutic Target in Recurrent Glioblastoma XenograftsCharlotte Degorre, Philip J Tofilon
Molecular Biology of the Cell|October 22, 2002
Radiation-induced activation of nuclear factor-kappaB involves selective degradation of plasma membrane-associated I(kappa)B(alpha)Jeffery S Russell, Philip J Tofilon
Radiation Oncology (London, England)|December 29, 2012
Preclinical models in radiation oncologyJenna Kahn, Philip J Tofilon, Kevin Camphausen
Current Topics in Developmental Biology|June 20, 2006
Histone deacetylation as a target for radiosensitizationDavid Cerna, Kevin Camphausen, Philip J Tofilon
International Journal of Molecular Sciences|September 13, 2025
Radiation Modifies Let-7 miRNA Binding to AGO2 Independent of Changes in Transcription to Influence Tumor Cell RadiosensitivityTaqveema Ali, Charlotte Degorre, Philip J Tofilon
Pageof 9